Study Evaluating Inotuzumab Ozogamicin (CMC-544) Plus Rituximab In Diffuse Large B-Cell Non-Hodgkin's Lymphoma

Memorial Sloan - Kettering Cancer Center, New York

Institut Paoli Calmettes, Marseille

Charite Campus Virchow-Kilinikum-, Berlin

Hopital Haut-Leveque, Pessac

CHU Saint-Eloi, Montpellier

University of Michigan Comprehensive Cancer Center, Ann Arbor

Pharmaceutical Research Center, Madison

CHRU de Lille Hopital Claude Huriez, Lille

Loyola University Medical Center, Foster G. McGraw Hospital and Satellites, Maywood

Washington University School of Medicine, St Louis

Siteman Cancer Center, City of Saint Peters

Departement d'Hematologie et d'Oncologie-, Strasbourg

CH Lyon Sud, Pierre-Bénite

Hopital Saint Louis, Paris

UT Southwestern University Hospital - St. Paul, Dallas

Zale Lipshy University Hospital, Dallas

UT Southwestern Medical Center, Dallas

University of Texas, MD Anderson Cancer Center, Houston

Methodist Healthcare System of, San Antonio

Singapore General Hospital, Singapore

Tufts Medical Center, Boston

Barnes-Jewish Hospital, St Louis

John Theurer Cancer Center (JTCC) at Hackensack University Medical Center (HUMC), Hackensack

John Theurer Cancer Center (JTCC) at Hackensack University Medical Center (HUMC), Hackensack

Hackensack University Medical CenteR, Hackensack

John Theurer Cancer Center (JTCC) at Hackensack University Medical Center (HUMC), Hackensack

John Theurer Cancer Center, Hackensack University Medical Center, Hackensack

Penn State Milton S Hershey Medical Center, Hershey

The University of Texas, M. D. Anderson Cancer Center, Houston

University of Wisconsin Hospital and Clinics, Madison

Samsung Medical Center, Seoul

Asan Medical Center, Seoul

Severance Hospital, Yonsei University Health System, Seoul

Christie Hospital, Manchester

The Christie NHS Foundation Trust, Manchester